Colossal Biosciences Tech Stack

CRISPR-based de-extinction and species restoration biotech

Biotechnology Research Dallas, TX 51–200 employees Privately Held

Colossal applies CRISPR and genome engineering to extinct and endangered species restoration. The tech stack is weighted toward wet-lab collaboration (Benchling, SnapGene, qPCR) and facility operations (Hyper-V, Proxmox, VLAN, iSCSI), with minimal cloud or data infrastructure — revealing a hardware-forward, lab-centric organization. Active hiring skews research-heavy (3 roles) alongside construction and veterinary program roles, matching their current focus on facility buildout and scaling animal programs.

Tech Stack 28 technologies

Core StackSlack Zoom Okta Zscaler DocuSign Active Directory Hyper-V Python Benchling SnapGene macOS Dante BrightSign Adobe Zoom Rooms DNS DHCP Red Hat Enterprise Linux Ubuntu Debian Bash Proxmox Meraki Dashboard VLAN iSCSI SCIM RADIUS qPCR

What Colossal Biosciences Is Building

◆Challenges

Building clinical systems from the ground up
Scaling veterinary programs
Expanding animal programs
Complex construction efforts
Multi-million-dollar project budgets

▲Active Projects

Clinical sop development for preventative medicine
Anesthesia protocol design
Facility construction planning
Base editing workflows
Species restoration
Avian de-extinction genetic engineering experiments
Multiplex genome engineering tools in mammalian cells
Specialized life sciences facility builds
Lab and facility activation and commissioning

Hiring Activity

Accelerating6 roles · 5 in 30d

Department

Research

Construction

Healthcare

Ops

Seniority

Mid

Senior

Junior

Company intelligence

Find more companies like Colossal Biosciences by tech stack, pain points and active projects

Get started free

About Colossal Biosciences

Colossal is a Dallas-based bioscience company developing genetic engineering technologies for species de-extinction and ecosystem restoration. The company combines CRISPR genome editing with species-specific protocols — currently working on avian de-extinction experiments, base editing workflows, and multiplex genome engineering in mammalian cells. Operationally, they are in heavy facility construction and commissioning phases while scaling clinical and veterinary programs, evidenced by active projects around anesthesia protocols, clinical SOPs, and specialized life sciences facility builds. The organization spans research, construction, healthcare, and operations with 51–200 employees.

HeadquartersDallas, TX

Company Size51–200 employees

Hiring MarketsUnited States

Frequently Asked Questions

What is Colossal Biosciences working on?

Avian de-extinction genetic engineering, base editing workflows, multiplex genome engineering in mammalian cells, and species restoration. Current operational focus includes clinical SOP development, anesthesia protocol design, and specialized life sciences facility construction and commissioning.

What tech stack does Colossal Biosciences use?

Benchling and SnapGene for molecular design; qPCR for lab analysis; Proxmox, Hyper-V, and Ubuntu/Debian for compute infrastructure; Okta and Active Directory for identity; Slack and Zoom for collaboration; Zscaler for security.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

SystImmune

Biotechnology Research

Vital Bio

Biotechnology Research

Praxis Precision Medicines, Inc.

Biotechnology Research

Alamar Biosciences, Inc.

Biotechnology Research

How this profile is built

Colossal Biosciences's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.